Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Name: Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder
SKU: 2912
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 39 No. 1 Articles Tags: andrea-fagiolini, atypical-antipsychotics, bimodal-treatment, bipolar-disorder, henry-a-nasrallah, mood-stabilizers, terence-a-ketter

Description

Description

Terence A. Ketter, MD

GENERAL PSYCHOPHARMACOLOGY

Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Terence A. Ketter, MD, Henry A. Nasrallah, MD, and Andrea Fagiolini, MD

120-146_PB_V39N1_Ketter

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Description

Terence A. Ketter, MD

GENERAL PSYCHOPHARMACOLOGY

Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Terence A. Ketter, MD, Henry A. Nasrallah, MD, and Andrea Fagiolini, MD

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder

Paul E. Keck, Jr., MD: Definition, Evaluation, and Management of Treatment Refractory Mania

Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Description

Terence A. Ketter, MD

GENERAL PSYCHOPHARMACOLOGY

Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Terence A. Ketter, MD, Henry A. Nasrallah, MD, and Andrea Fagiolini, MD

Related products

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder

Paul E. Keck, Jr., MD: Definition, Evaluation, and Management of Treatment Refractory Mania

Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing